Padilla ÁS, Torres CR

Language: Spanish
References: 5
Page: 470-472
PDF size: 182.29 Kb.

ABSTRACT

Drug use in Mexico remains a significant public health concern, primarily due to the complications arising from intoxication, in addition to the challenges associated with addiction. We present the case of a female patient with an atypical clinical presentation secondary to the combined use of cocaine and fentanyl. This case highlights the diagnostic and therapeutic complexities involved in such scenarios, the increasing prevalence of fentanyl-adulterated substances, and the urgent need for greater awareness and rapid response systems in these situations.

REFERENCES

1. Comisión Nacional de Salud Mental y Adicciones. Contexto de la demanda de sustancias ilícitas en 2022-2023 y acciones del Gobierno de México en materia de salud mental y adicciones. Ciudad de México: Secretaría de Salud; 2024.

2. Gorelick D. Cocaine use disorder. Epidemiology, clinical features, and diagnosis. In: UpToDate [Internet]. Wolters Kluwer; 2023.

3. Richards JR, Mefford JM, Patel JJ, Parikh AK, Eder AZ, Elder JW. The association between cocaine use detected on drug screening and rhabdomyolysis. Toxicol Commun. 2020; 4 (1): 18-24.

4. Khatri UG, Viner K, Perrone J. Lethal fentanyl and cocaine intoxication. N Engl J Med. 2018; 379 (18): 1782.

5. Drug Enforcement Administration. Cocaine/fentanyl combination in Pennsylvania. Washington, D.C.: DEA Bulletin; 2018.